← Evidence map

RetractedTrialComputational intelligence and neuroscience2022

Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung.

Zizong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36438688